These accolades not only recognize XMJ's exceptional performance and business growth in the Asia-Pacific region but also reflect its unwavering commitment to excellence in the fields of biopharmaceuticals and clinical diagnostics. These achievements underscore XMJ's dedication to advancing industry innovation and development, as well as its strong professional capabilities and resilient spirit in overcoming challenges. The company is committed to delivering high-quality clinical diagnostic products and services, continuously driving technological innovation to meet evolving market demands.

KPL (Kinetic Plasmonics Laboratories) is a globally recognized company with a long-standing reputation in the field of biosciences. As one of the earliest companies worldwide to commercialize affinity-purified secondary antibodies, KPL has established a solid foundation through its pioneering role in this domain. Additionally, KPL is among the world's largest manufacturers of secondary antibodies and substrate chromogenic systems, with nearly 40 years of experience in product research and development, accumulating extensive expertise and technical capabilities. The company has obtained ISO13485 quality system certification, ensuring minimal batch-to-batch variation and consistent product quality. KPL's products are known for their high purity, high sensitivity, and excellent signal-to-noise ratio (strong signal, low background), earning the trust of researchers and diagnostic enterprises globally. In 2013, KPL became part of SeraCare, a leading supplier of in vitro diagnostic reagents, further strengthening its leadership in the industry. SeraCare, founded in 1984, is a key partner for global in vitro diagnostic manufacturers and clinical laboratories. It joined the LGC Group in 2018.

Beijing XMJ Scientific Co., Ltd. (hereinafter referred to as "XMJ") was founded in 2006 by U.S.-trained professionals in the field of biology. It is a high-tech enterprise specializing in the distribution of imported reagents, technical services, and contract development, with the mission of providing world-class products and services for the advancement of life sciences. Over the past 19 years, XMJ has effectively integrated global premium resources and delivered a comprehensive range of professional products and services to its clients. These include cell culture medium components, GMP-grade transfection reagents, pharma-grade biochemical reagents, purification resin and chromatography columns, GMP-grade nucleases, HCP/HCD detection kits, Protein A/BSA/MVM bioprocess impurity residue detection kits, CE-SDS protein analysis kits, injectable pharmaceutical excipients, pharmacopoeia reference standards, hyaluronidase, antigens/antibodies/substrates, HCP antibody coverage verification and custom kit development services, and tubing consumables. XMJ meets the one-stop needs of customers from research and development to production, covering areas such as cell culture, transfection, purification, quality control, formulation, and drug evaluation. The company holds import and export qualifications and operates its own international logistics network. It has established long-term and stable partnerships with over 40 domestic and international suppliers of reagents, raw materials, instrument consumables, and technical services, including renowned brands such as PanReac AppliChem, Cygnus Technologies, Pfanstiehl, Mirus, Astrea Bioseparations, KPL, ZF Bio, and PanoTech Bio Materials. With continuous business expansion, XMJ has successively established branches in Shanghai, Guangzhou, Chengdu, Wuhan, and other major cities, becoming a designated supplier for procurement platforms of domestic biopharmaceutical enterprises, diagnostic companies, multinational pharmaceutical firms, and various universities and research institutions. As a result, XMJ has earned the support and trust of a broad customer base.